Andrew Carridge #
Andrew Carridge is a Partner at Reddie & Grose and a UK and European Patent Attorney based in the firm’s Cambridge office. He handles patents in a wide range of areas within the life sciences sector.
Andrew has a Master’s degree in Biochemistry from Oxford University, and prior to joining Reddie & Grose, gained commercial research and development experience at Unilever where he assisted in the development of innovative formulations for a number of well-known brands.
Andrew has many years of experience in the profession, assisting clients with drafting, filing and prosecuting patent applications in the UK, Europe and around the world; and at opposition and appeal proceedings at the European Patent Office. He also advises on freedom to operate, patentability, due diligence, inventorship and assignment matters, assisting clients in obtaining supplementary protection certificates (SPC) and advising on strategies for maximising exclusivity for approved drugs, in Europe.
Andrew acts for a wide range of clients including start-ups, multinational companies and academic institutions within the life sciences and chemical sectors. He has experience in a number of technical areas including antimicrobial formulations, tissue regeneration, pharmaceuticals and biologics (including antibodies), disease diagnosis and nucleic acid sequencing. Andrew also assists clients in other technical areas such as medical devices, industrial processing of biomass and materials.
Publications in the media:
- Tomorrow’s renewable ambitions depend on today’s innovations
- Net-zero by 2050: Tomorrow’s clean energy ambitions